COPS5 and intrahepatic cholangiocarcinoma: However, there was no statistically significant relationship between Jab1/COPS5 and clinicopathological parameters or patient survival in intrahepatic cholangiocarcinomas and HCC (Berg et al., 2007; Hashimoto et al., 2009).